Get the app!
Back to Trades

Doyle Mittie

InsiderCIK 0001918845

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
16
Buy transactions
0
Sell transactions
15
Companies
2
Active
2025–2026

Doyle Mittie accounts for 16 disclosed filings worth $8.0M, spread across 2 companies, active 2025–2026. The record is heavily weighted toward selling, with $0 in purchases against $2.5M in sales. Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

16 loaded
Sep 1AVTX
Avalo Therapeutics, Inc.
Doyle MittieInsiderSell$13.6K
Aug 19AVTX
Avalo Therapeutics, Inc.
Doyle MittieInsiderSell$20.0K
Aug 12AVTX
Avalo Therapeutics, Inc.
Doyle MittieInsiderSell$13.6K
Jul 29AVTX
Avalo Therapeutics, Inc.
Doyle MittieInsiderSell$20.0K
Jun 25AVTX
Avalo Therapeutics, Inc.
Doyle MittieInsiderSell$26.1K
Jun 18CGEM
Cullinan Therapeutics, Inc.
Doyle MittieInsiderAward$295.1K
Jun 12AVTX
Avalo Therapeutics, Inc.
Doyle MittieInsiderTax withheld$14.2K
Jun 1AVTX
Avalo Therapeutics, Inc.
Doyle MittieInsiderSell$10.9K
May 26AVTX
Avalo Therapeutics, Inc.
Doyle MittieInsiderGrant$0
May 19AVTX
Avalo Therapeutics, Inc.
Doyle MittieInsiderSell$56.3K
May 7AVTX
Avalo Therapeutics, Inc.
Doyle MittieInsiderSell$2.2M
Apr 8AVTX
Avalo Therapeutics, Inc.
Doyle MittieInsiderSell$71.5K
Apr 3AVTX
Avalo Therapeutics, Inc.
Doyle MittieInsiderSell$10.9K
Mar 2AVTX
Avalo Therapeutics, Inc.
Doyle MittieInsiderAward$1.9M
Aug 8CGEM
Cullinan Therapeutics, Inc.
Doyle MittieInsiderAward$558.6K
Aug 8CGEM
Cullinan Therapeutics, Inc.
Doyle MittieInsiderOther$0

16 filings